clenbuterol has been researched along with Muscular Dystrophy in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Excerpt | Relevance | Reference |
---|---|---|
"We report the outcome of trial of clenbuterol in four adult muscular dystrophy patients." | 9.09 | [Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies]. ( Kawai, M; Ogawa, M; Oya, Y, 2001) |
"We report the outcome of trial of clenbuterol in four adult muscular dystrophy patients." | 5.09 | [Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies]. ( Kawai, M; Ogawa, M; Oya, Y, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oya, Y | 1 |
Ogawa, M | 1 |
Kawai, M | 1 |
1 trial available for clenbuterol and Muscular Dystrophy
Article | Year |
---|---|
[Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies].
Topics: Adrenergic beta-Agonists; Adult; Clenbuterol; Female; Humans; Male; Middle Aged; Muscular Dystrophie | 2001 |